MarketCap
Baxter International BAX
€ 22.67
-0.04%
Facebook
X
Telegram
Baxter International Betriebsaufwand | BAX
Betriebsaufwand Jährlich Baxter International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 3.88 B | 3.13 B | 3.2 B | 3.39 B | 3.7 B | 5.45 B | 4.93 B | 4.48 B | 4.1 B | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.45 B | 3.13 B | 4.03 B |
Betriebsaufwand anderer Aktien in der Medizinische Instrumente
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
17.8 M | $ 38.61 | 3.51 % | $ 1.84 B |  USA |
 |
Harvard Bioscience
HBIO
|
98.5 M | $ 8.32 | 1.09 % | $ 369 M | USA |
 |
ICU Medical
ICUI
|
779 M | $ 165.91 | -0.46 % | $ 4.09 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 13.8 | -1.0 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 121.86 | 0.49 % | $ 3.9 B | USA |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 451.72 | -0.13 % | $ 161 B | USA |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 84.26 | -0.22 % | $ 1.91 B | USA |
 |
Nephros
NEPH
|
10.5 M | $ 3.6 | 1.98 % | $ 38.2 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 23.68 | 0.32 % | $ 3.98 B | USA |
 |
OraSure Technologies
OSUR
|
120 M | $ 4.17 | 0.97 % | $ 306 M | USA |
 |
Pro-Dex
PDEX
|
11.3 M | $ 61.53 | -1.11 % | $ 198 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 52.77 | -0.47 % | $ 3.56 B | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 180.01 | 1.74 % | $ 10.1 M | USA |
 |
ResMed
RMD
|
1.57 B | $ 253.31 | 0.18 % | $ 36.9 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.58 | -0.02 % | $ 17.4 M | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 23.16 | 2.43 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
1.52 B | $ 229.89 | -0.97 % | $ 22.6 B | USA |
 |
Stereotaxis
STXS
|
39.2 M | $ 0.99 | -2.99 % | $ 90 M | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 137.03 | 0.54 % | $ 6.11 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 73.36 | -1.17 % | $ 238 M | USA |
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 395.17 | 0.77 % | $ 28.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 9.22 | -2.28 % | $ 1.84 B | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
215 M | $ 12.17 | -1.62 % | $ 505 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 195.87 | -1.37 % | $ 56.3 B | USA |
 |
The Cooper Companies
COO
|
1.23 B | $ 61.11 | -0.16 % | $ 12.2 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 7.51 | 6.52 % | $ 63.7 K | USA |
 |
Glaukos Corporation
GKOS
|
482 M | $ 178.61 | -0.15 % | $ 10.2 B | USA |
 |
Haemonetics Corporation
HAE
|
631 M | $ 119.33 | 0.69 % | $ 5.63 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 3.13 | -1.26 % | $ 145 M | USA |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.31 | 1.02 % | $ 25.4 M | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 94.16 | 0.92 % | $ 5.57 B | USA |
 |
Alcon
ALC
|
3.37 B | $ 70.0 | -0.24 % | $ 34.5 B |  Schweiz |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
AtriCure
ATRC
|
410 M | $ 61.13 | 3.66 % | $ 2.92 B | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 0.95 | -2.44 % | $ 43.5 M |  Israel |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
1.27 B | - | - | $ 9.59 B | USA |
 |
Predictive Oncology
POAI
|
10.3 M | - | - | $ 31.1 M | USA |